230 related articles for article (PubMed ID: 32697667)
21. Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review.
Abdallah A; Chang JL; O'Carroll CB; Musubire A; Chow FC; Wilson AL; Siedner MJ
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1828-1836. PubMed ID: 29628338
[TBL] [Abstract][Full Text] [Related]
22. Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries.
Awopegba OE; Kalu A; Ahinkorah BO; Seidu AA; Ajayi AI
PLoS One; 2020; 15(11):e0242001. PubMed ID: 33166351
[TBL] [Abstract][Full Text] [Related]
23. Stigma Mechanisms and Outcomes among Sub-Saharan African Descendants in Belgium-Contextualizing the HIV Stigma Framework.
Manirankunda L; Wallace A; Ddungu C; Nöstlinger C
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444384
[TBL] [Abstract][Full Text] [Related]
24. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study.
Strother RM; Gopal S; Wirth M; Chadburn A; Noy A; Cesarman E; Lee JY; Remick SC; Busakhala N; Kaimila B; Mberi E; Ndlovu N; Omoding A; Krown SE
JCO Glob Oncol; 2020 Jul; 6():1034-1040. PubMed ID: 32634068
[TBL] [Abstract][Full Text] [Related]
25. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
Agonnoude MT; Mesenge C
Sante; 2010; 20(2):116-24. PubMed ID: 20685643
[TBL] [Abstract][Full Text] [Related]
26. Tackling an emerging epidemic: the burden of non-communicable diseases among people living with HIV/AIDS in sub-Saharan Africa.
Achwoka D; Mutave R; Oyugi JO; Achia T
Pan Afr Med J; 2020; 36():271. PubMed ID: 33088400
[TBL] [Abstract][Full Text] [Related]
27. Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013.
Adedokun BO; Olopade CO; Olopade OI
Glob Health Action; 2016; 9():31026. PubMed ID: 27178644
[TBL] [Abstract][Full Text] [Related]
28. Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.
Grover S; Zetola N; Ramogola-Masire D; Bvochora-Nsingo M; Schnader AF; Mick R; Gabaitiri L; Matlhagela K; Shen H; Chiyapo S; Balang D; Phaladze N; Nkomazana O; Friedman H; Jemmott J; Chilisa B; Robertson ES
BMJ Open; 2019 Dec; 9(12):e031103. PubMed ID: 31892649
[TBL] [Abstract][Full Text] [Related]
29. Systematic review: a review of adolescent behavior change interventions [BCI] and their effectiveness in HIV and AIDS prevention in sub-Saharan Africa.
Mwale M; Muula AS
BMC Public Health; 2017 Sep; 17(1):718. PubMed ID: 28923040
[TBL] [Abstract][Full Text] [Related]
30. Effective interventions to improve young adults' linkage to HIV care in Sub-Saharan Africa: a systematic review.
Mavegam BO; Pharr JR; Cruz P; Ezeanolue EE
AIDS Care; 2017 Oct; 29(10):1198-1204. PubMed ID: 28325077
[TBL] [Abstract][Full Text] [Related]
31. A biobank to support HIV malignancy research for sub-Saharan Africa.
Schneider JW; Sanderson M; Geiger D; Nokta M; Silver S
S Afr Med J; 2016 Aug; 106(9):867-9. PubMed ID: 27601106
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
Todowede OO; Mianda SZ; Sartorius B
Syst Rev; 2019 Jan; 8(1):4. PubMed ID: 30606249
[TBL] [Abstract][Full Text] [Related]
33. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
34. Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006).
Burkhalter JE; Aboulafia DM; Botello-Harbaum M; Lee JY
HIV Clin Trials; 2018 Dec; 19(6):235-241. PubMed ID: 30890062
[TBL] [Abstract][Full Text] [Related]
35. Evaluating HIV/Aids prevalence and sustainable development in sub-Saharan Africa: the role of health expenditure.
Odugbesan JA; Rjoub H
Afr Health Sci; 2020 Jun; 20(2):568-578. PubMed ID: 33163018
[TBL] [Abstract][Full Text] [Related]
36. From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review.
Juma K; Reid M; Roy M; Vorkoper S; Temu TM; Levitt NS; Oladepo O; Zakus D; Yonga G
AIDS; 2018 Jul; 32 Suppl 1():S63-S73. PubMed ID: 29952792
[TBL] [Abstract][Full Text] [Related]
37. Scaling up pre-exposure prophylaxis in sub-Saharan Africa.
Ahmed N; Pike C; Bekker LG
Curr Opin Infect Dis; 2019 Feb; 32(1):24-30. PubMed ID: 30461452
[TBL] [Abstract][Full Text] [Related]
38. Why is mother to child transmission (MTCT) of HIV a continual threat to new-borns in sub-Saharan Africa (SSA).
Yah CS; Tambo E
J Infect Public Health; 2019; 12(2):213-223. PubMed ID: 30415979
[TBL] [Abstract][Full Text] [Related]
39. Interventions targeting sexual and reproductive health and rights outcomes of young people living with HIV: a comprehensive review of current interventions from sub-Saharan Africa.
Pretorius L; Gibbs A; Crankshaw T; Willan S
Glob Health Action; 2015; 8():28454. PubMed ID: 26534721
[TBL] [Abstract][Full Text] [Related]
40. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
